Merrimack Pharmaceuticals Inc: DEFA14A filed Feb 13, 2024

Form type

DEFA14A

Filing date

Feb 13, 2024

Accession number

0001193125-24-033779

Filer

Merrimack Pharmaceuticals Inc (CIK 1274792)